Global Parkinson's Disease Therapeutics Market Analysis 2015-2019 and Forecast 2020-2025

Publisher Name :
Date: 04-Mar-2020
No. of pages: 114

Snapshot

The global Parkinson's Disease Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Parkinson's Disease Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

- Medications Therapeutics

- Medical Devices Therapeutics

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

- GSK

- Novartis

- Boehringer Ingelheim

- Teva Pharmaceutical

- Abbvie

- Merck

- Akorn

- Kyowa Hakko Kirin Pharma

- Astellas Pharma

- Desitin Arzneimittel

- Endo Pharmaceuticals

- F.Hoffmann-La Roche

- H.Lundbeck

- Valeant

- Apokyn

- Orion

- Stada Arzneimittel

- US WorldMeds

- Bausch Health

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

- Under 40 Years Old

- 40-65 Years Old

- Above 65 Years Old

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

- North America (U.S., Canada, Mexico)

- Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

- Asia-Pacific (China, India, Japan, Southeast Asia etc.)

- South America (Brazil, Argentina etc.)

- Middle East & Africa (Saudi Arabia, South Africa etc.)

Global Parkinson's Disease Therapeutics Market Analysis 2015-2019 and Forecast 2020-2025

Table of Contents

1 Industry Overview
1.1 Parkinson's Disease Therapeutics Industry
Figure Parkinson's Disease Therapeutics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Parkinson's Disease Therapeutics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Parkinson's Disease Therapeutics
1.2.2 Downstream
Table Application Segment of Parkinson's Disease Therapeutics
Table Global Parkinson's Disease Therapeutics Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Parkinson's Disease Therapeutics Market by Type
3.1 By Type
3.1.1 Medications Therapeutics
Table Major Company List of Medications Therapeutics
3.1.2 Medical Devices Therapeutics
Table Major Company List of Medical Devices Therapeutics
3.2 Market Size
Table Global Parkinson's Disease Therapeutics Market 2015-2019, by Type, in USD Million
Figure Global Parkinson's Disease Therapeutics Market Growth 2015-2019, by Type, in USD Million
Table Global Parkinson's Disease Therapeutics Market 2015-2019, by Type, in Volume
Figure Global Parkinson's Disease Therapeutics Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Parkinson's Disease Therapeutics Market Forecast 2020-2025, by Type, in USD Million
Table Global Parkinson's Disease Therapeutics Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 GSK (Company Profile, Sales Data etc.)
4.1.1 GSK Profile
Table GSK Overview List
4.1.2 GSK Products & Services
4.1.3 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Novartis (Company Profile, Sales Data etc.)
4.2.1 Novartis Profile
Table Novartis Overview List
4.2.2 Novartis Products & Services
4.2.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.3.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.3.2 Boehringer Ingelheim Products & Services
4.3.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Teva Pharmaceutical (Company Profile, Sales Data etc.)
4.4.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
4.4.2 Teva Pharmaceutical Products & Services
4.4.3 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Abbvie (Company Profile, Sales Data etc.)
4.5.1 Abbvie Profile
Table Abbvie Overview List
4.5.2 Abbvie Products & Services
4.5.3 Abbvie Business Operation Conditions
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Merck (Company Profile, Sales Data etc.)
4.6.1 Merck Profile
Table Merck Overview List
4.6.2 Merck Products & Services
4.6.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Akorn (Company Profile, Sales Data etc.)
4.7.1 Akorn Profile
Table Akorn Overview List
4.7.2 Akorn Products & Services
4.7.3 Akorn Business Operation Conditions
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Kyowa Hakko Kirin Pharma (Company Profile, Sales Data etc.)
4.8.1 Kyowa Hakko Kirin Pharma Profile
Table Kyowa Hakko Kirin Pharma Overview List
4.8.2 Kyowa Hakko Kirin Pharma Products & Services
4.8.3 Kyowa Hakko Kirin Pharma Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Astellas Pharma (Company Profile, Sales Data etc.)
4.9.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
4.9.2 Astellas Pharma Products & Services
4.9.3 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Desitin Arzneimittel (Company Profile, Sales Data etc.)
4.10.1 Desitin Arzneimittel Profile
Table Desitin Arzneimittel Overview List
4.10.2 Desitin Arzneimittel Products & Services
4.10.3 Desitin Arzneimittel Business Operation Conditions
Table Business Operation of Desitin Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Endo Pharmaceuticals (Company Profile, Sales Data etc.)
4.11.1 Endo Pharmaceuticals Profile
Table Endo Pharmaceuticals Overview List
4.11.2 Endo Pharmaceuticals Products & Services
4.11.3 Endo Pharmaceuticals Business Operation Conditions
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 F.Hoffmann-La Roche (Company Profile, Sales Data etc.)
4.12.1 F.Hoffmann-La Roche Profile
Table F.Hoffmann-La Roche Overview List
4.12.2 F.Hoffmann-La Roche Products & Services
4.12.3 F.Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F.Hoffmann-La Roche (Sales Revenue, Cost, Gross Margin)
4.13 H.Lundbeck (Company Profile, Sales Data etc.)
4.13.1 H.Lundbeck Profile
Table H.Lundbeck Overview List
4.13.2 H.Lundbeck Products & Services
4.13.3 H.Lundbeck Business Operation Conditions
Table Business Operation of H.Lundbeck (Sales Revenue, Cost, Gross Margin)
4.14 Valeant (Company Profile, Sales Data etc.)
4.14.1 Valeant Profile
Table Valeant Overview List
4.14.2 Valeant Products & Services
4.14.3 Valeant Business Operation Conditions
Table Business Operation of Valeant (Sales Revenue, Cost, Gross Margin)
4.15 Apokyn (Company Profile, Sales Data etc.)
4.15.1 Apokyn Profile
Table Apokyn Overview List
4.15.2 Apokyn Products & Services
4.15.3 Apokyn Business Operation Conditions
Table Business Operation of Apokyn (Sales Revenue, Cost, Gross Margin)
4.16 Orion (Company Profile, Sales Data etc.)
4.16.1 Orion Profile
Table Orion Overview List
4.16.2 Orion Products & Services
4.16.3 Orion Business Operation Conditions
Table Business Operation of Orion (Sales Revenue, Cost, Gross Margin)
4.17 Stada Arzneimittel (Company Profile, Sales Data etc.)
4.17.1 Stada Arzneimittel Profile
Table Stada Arzneimittel Overview List
4.17.2 Stada Arzneimittel Products & Services
4.17.3 Stada Arzneimittel Business Operation Conditions
Table Business Operation of Stada Arzneimittel (Sales Revenue, Cost, Gross Margin)
4.18 US WorldMeds (Company Profile, Sales Data etc.)
4.18.1 US WorldMeds Profile
Table US WorldMeds Overview List
4.18.2 US WorldMeds Products & Services
4.18.3 US WorldMeds Business Operation Conditions
Table Business Operation of US WorldMeds (Sales Revenue, Cost, Gross Margin)
4.19 Bausch Health (Company Profile, Sales Data etc.)
4.19.1 Bausch Health Profile
Table Bausch Health Overview List
4.19.2 Bausch Health Products & Services
4.19.3 Bausch Health Business Operation Conditions
Table Business Operation of Bausch Health (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Parkinson's Disease Therapeutics Sales Revenue 2015-2019, by Company, in USD Million
Table Global Parkinson's Disease Therapeutics Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Parkinson's Disease Therapeutics Sales Revenue Share in 2019, by Company, in USD Million
Table Global Parkinson's Disease Therapeutics Sales Volume 2015-2019, by Company, in Volume
Table Global Parkinson's Disease Therapeutics Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Parkinson's Disease Therapeutics Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Parkinson's Disease Therapeutics Market Concentration, in 2019
Figure Europe Parkinson's Disease Therapeutics Market Market Concentration, in 2019
Figure Asia-Pacific Parkinson's Disease Therapeutics MMarket Concentration, in 2019
Figure South America Parkinson's Disease Therapeutics Market Concentration, in 2019
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Under 40 Years Old
Figure Parkinson's Disease Therapeutics Demand in Under 40 Years Old, 2015-2019, in USD Million
Figure Parkinson's Disease Therapeutics Demand in Under 40 Years Old, 2015-2019, in Volume
6.1.2 Demand in 40-65 Years Old
Figure Parkinson's Disease Therapeutics Demand in 40-65 Years Old, 2015-2019, in USD Million
Figure Parkinson's Disease Therapeutics Demand in 40-65 Years Old, 2015-2019, in Volume
6.1.3 Demand in Above 65 Years Old
Figure Parkinson's Disease Therapeutics Demand in Above 65 Years Old, 2015-2019, in USD Million
Figure Parkinson's Disease Therapeutics Demand in Above 65 Years Old, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Parkinson's Disease Therapeutics Demand Forecast 2020-2025, by Application, in USD Million
Figure Parkinson's Disease Therapeutics Market Growth 2020-2025, by Application, in USD Million
Figure Parkinson's Disease Therapeutics Market Share in 2025, by Application, in USD Million
Table Parkinson's Disease Therapeutics Demand Forecast 2020-2025, by Application, in Volume
Table Parkinson's Disease Therapeutics Market Growth 2020-2025, by Application, in Volume
Table Parkinson's Disease Therapeutics Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Parkinson's Disease Therapeutics Production 2015-2019, by Region, in USD Million
Table Parkinson's Disease Therapeutics Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Parkinson's Disease Therapeutics Market 2015-2019, by Region, in USD Million
Table Global Parkinson's Disease Therapeutics Market Share 2015-2019, by Region, in USD Million
Table Global Parkinson's Disease Therapeutics Market 2015-2019, by Region, in Volume
Table Global Parkinson's Disease Therapeutics Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure North America Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table North America Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Europe Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Europe Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure South America Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table South America Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Parkinson's Disease Therapeutics Market Forecast 2020-2025, by Region, in USD Million
Table Parkinson's Disease Therapeutics Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Tables

Table Upstream Segment of Parkinson's Disease Therapeutics
Table Application Segment of Parkinson's Disease Therapeutics
Table Global Parkinson's Disease Therapeutics Market 2015-2025, by Application, in USD Million
Table Major Company List of Medical Devices Therapeutics
Table Global Parkinson's Disease Therapeutics Market 2015-2019, by Type, in USD Million
Table Global Parkinson's Disease Therapeutics Market 2015-2019, by Type, in Volume
Table Global Parkinson's Disease Therapeutics Market Forecast 2020-2025, by Type, in USD Million
Table Global Parkinson's Disease Therapeutics Market Forecast 2020-2025, by Type, in Volume
Table GSK Overview List
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbvie Overview List
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Akorn Overview List
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Pharma Overview List
Table Business Operation of Kyowa Hakko Kirin Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Overview List
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Desitin Arzneimittel Overview List
Table Business Operation of Desitin Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Pharmaceuticals Overview List
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F.Hoffmann-La Roche Overview List
Table Business Operation of F.Hoffmann-La Roche (Sales Revenue, Cost, Gross Margin)
Table H.Lundbeck Overview List
Table Business Operation of H.Lundbeck (Sales Revenue, Cost, Gross Margin)
Table Valeant Overview List
Table Business Operation of Valeant (Sales Revenue, Cost, Gross Margin)
Table Apokyn Overview List
Table Business Operation of Apokyn (Sales Revenue, Cost, Gross Margin)
Table Orion Overview List
Table Business Operation of Orion (Sales Revenue, Cost, Gross Margin)
Table Stada Arzneimittel Overview List
Table Business Operation of Stada Arzneimittel (Sales Revenue, Cost, Gross Margin)
Table US WorldMeds Overview List
Table Business Operation of US WorldMeds (Sales Revenue, Cost, Gross Margin)
Table Bausch Health Overview List
Table Business Operation of Bausch Health (Sales Revenue, Cost, Gross Margin)
Table Global Parkinson's Disease Therapeutics Sales Revenue 2015-2019, by Company, in USD Million
Table Global Parkinson's Disease Therapeutics Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Parkinson's Disease Therapeutics Sales Volume 2015-2019, by Company, in Volume
Table Global Parkinson's Disease Therapeutics Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Parkinson's Disease Therapeutics Demand Forecast 2020-2025, by Application, in USD Million
Table Parkinson's Disease Therapeutics Demand Forecast 2020-2025, by Application, in Volume
Table Parkinson's Disease Therapeutics Market Growth 2020-2025, by Application, in Volume
Table Parkinson's Disease Therapeutics Market Share in 2025, by Application, in Volume
Table Parkinson's Disease Therapeutics Production 2015-2019, by Region, in USD Million
Table Parkinson's Disease Therapeutics Production 2015-2019, by Region, in Volume
Table Global Parkinson's Disease Therapeutics Market 2015-2019, by Region, in USD Million
Table Global Parkinson's Disease Therapeutics Market Share 2015-2019, by Region, in USD Million
Table Global Parkinson's Disease Therapeutics Market 2015-2019, by Region, in Volume
Table Global Parkinson's Disease Therapeutics Market Share 2015-2019, by Region, in Volume
Table North America Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table North America Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
Table Europe Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Europe Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
Table South America Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table South America Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Parkinson's Disease Therapeutics Market Size 2015-2019, by Country, in Volume
Table Parkinson's Disease Therapeutics Market Forecast 2020-2025, by Region, in USD Million
Table Parkinson's Disease Therapeutics Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List

List of Figures

Figure Parkinson's Disease Therapeutics Industry Chain Structure
Figure Global Parkinson's Disease Therapeutics Market Growth 2015-2019, by Type, in USD Million
Figure Global Parkinson's Disease Therapeutics Market Growth 2015-2019, by Type, in Volume
Figure Global Parkinson's Disease Therapeutics Sales Revenue Share in 2019, by Company, in USD Million
Figure Global Parkinson's Disease Therapeutics Sales Volume Share in 2019, by Company, in Volume
Figure North America Parkinson's Disease Therapeutics Market Concentration, in 2019
Figure Europe Parkinson's Disease Therapeutics Market Market Concentration, in 2019
Figure Asia-Pacific Parkinson's Disease Therapeutics MMarket Concentration, in 2019
Figure South America Parkinson's Disease Therapeutics Market Concentration, in 2019
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Concentration, in 2019
Figure Parkinson's Disease Therapeutics Demand in Under 40 Years Old, 2015-2019, in USD Million
Figure Parkinson's Disease Therapeutics Demand in Under 40 Years Old, 2015-2019, in Volume
Figure Parkinson's Disease Therapeutics Demand in 40-65 Years Old, 2015-2019, in USD Million
Figure Parkinson's Disease Therapeutics Demand in 40-65 Years Old, 2015-2019, in Volume
Figure Parkinson's Disease Therapeutics Demand in Above 65 Years Old, 2015-2019, in USD Million
Figure Parkinson's Disease Therapeutics Demand in Above 65 Years Old, 2015-2019, in Volume
Figure Parkinson's Disease Therapeutics Market Growth 2020-2025, by Application, in USD Million
Figure Parkinson's Disease Therapeutics Market Share in 2025, by Application, in USD Million
Figure North America Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure North America Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
Figure Europe Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Europe Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
Figure Asia-Pacific Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
Figure South America Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure South America Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size and Growth 2015-2019, in Volume
Figure Marketing Channels Overview
  • Global Parkinson's Disease Therapeutics Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99
    Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
  • Global Amantadine Hydrochloride Market Insights, Forecast to 2029
    Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
  • Global Rasagiline Tablet Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107
    Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
  • Global Parkinsons Disease Drug Market Insights, Forecast to 2029
    Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113
    Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......
  • Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Amantadine Hydrochloride Market Research Report 2023
    Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......
  • Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs